Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1980 1
1981 1
1982 1
1983 1
1986 1
1988 2
1989 1
1991 4
1993 4
1994 1
1995 5
1996 1
1997 6
1998 8
1999 5
2000 10
2001 12
2002 9
2003 9
2004 13
2005 22
2006 19
2007 16
2008 25
2009 19
2010 34
2011 32
2012 36
2013 45
2014 41
2015 62
2016 61
2017 69
2018 71
2019 82
2020 101
2021 86
2022 86
2023 95
2024 42

Text availability

Article attribute

Article type

Publication date

Search Results

1,013 results

Results by year

Filters applied: . Clear all
Page 1
A simultaneous strategy for the preparation of acetylation modified cellulose nanofiber/polypropylene composites.
Duan L, Liu R, Duan Y, Li Z, Li Q. Duan L, et al. Carbohydr Polym. 2022 Feb 1;277:118744. doi: 10.1016/j.carbpol.2021.118744. Epub 2021 Oct 18. Carbohydr Polym. 2022. PMID: 34893208
In this study, a simultaneous method with nano-fibrillation of acetylation modified fibers (A-cellulose) and preparation of cellulose nanofiber (CNF)/apolar polymer composites are proposed. ...Due to the reduction of hydrogen bonding force inside A-cellulose and the high s …
In this study, a simultaneous method with nano-fibrillation of acetylation modified fibers (A-cellulose) and preparation of cellulose …
Pretargeted Imaging and Therapy.
Altai M, Membreno R, Cook B, Tolmachev V, Zeglis BM. Altai M, et al. J Nucl Med. 2017 Oct;58(10):1553-1559. doi: 10.2967/jnumed.117.189944. Epub 2017 Jul 7. J Nucl Med. 2017. PMID: 28687600 Free PMC article. Review.
In vivo pretargeting stands as a promising approach to harnessing the exquisite tumor-targeting properties of antibodies for nuclear imaging and therapy while simultaneously skirting their pharmacokinetic limitations. The core premise of pretargeting lies in adminis …
In vivo pretargeting stands as a promising approach to harnessing the exquisite tumor-targeting properties of antibodies for nuclear imag …
Chromatically Corrected Multicolor Multiphoton Microscopy.
Blanc H, Kaddour G, David NB, Supatto W, Livet J, Beaurepaire E, Mahou P. Blanc H, et al. ACS Photonics. 2023 Nov 6;10(12):4104-4111. doi: 10.1021/acsphotonics.3c01104. eCollection 2023 Dec 20. ACS Photonics. 2023. PMID: 38145164 Free PMC article.
Simultaneous imaging of multiple labels in tissues is key to studying complex biological processes. ...We illustrate this approach with simultaneous three-color, two-photon imaging of developing zebrafish embryos and fixed Brainbow mouse brain slices o …
Simultaneous imaging of multiple labels in tissues is key to studying complex biological processes. ...We illustrate this appr …
Functional imaging for hyperparathyroidism.
Huglo PD. Huglo PD. Presse Med. 2022 Jun;51(2):104120. doi: 10.1016/j.lpm.2022.104120. Epub 2022 Mar 20. Presse Med. 2022. PMID: 35321847
Currently, parathyroid radionuclide imaging is based on two techniques, parathyroid scintigraphy and (18)F-fluorocholine - positron emission tomography (PET). ...That said, due to a lack of specificity in (18)F-fluorocholine uptake, which has been observed on inflam …
Currently, parathyroid radionuclide imaging is based on two techniques, parathyroid scintigraphy and (18)F-fluorocholine - pos …
Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics.
Chakraborty K, Mondal J, An JM, Park J, Lee YK. Chakraborty K, et al. Pharmaceutics. 2023 Mar 17;15(3):971. doi: 10.3390/pharmaceutics15030971. Pharmaceutics. 2023. PMID: 36986832 Free PMC article. Review.
Radiopharmaceutical therapy, which can detect and treat tumours simultaneously, was introduced more than 80 years ago, and it has changed medical strategies with respect to cancer. ...The increased use of peptide receptor radionuclide therapy (PRRT) is also i …
Radiopharmaceutical therapy, which can detect and treat tumours simultaneously, was introduced more than 80 years ago, and it has cha …
Imaging of atherosclerosis.
Takx RA, Partovi S, Ghoshhajra BB. Takx RA, et al. Int J Cardiovasc Imaging. 2016 Jan;32(1):5-12. doi: 10.1007/s10554-015-0730-y. Epub 2015 Aug 4. Int J Cardiovasc Imaging. 2016. PMID: 26239134 Review.
Ultrasound, computed tomography, magnetic resonance imaging (MRI), positron emission tomography (PET) and interventional angiography are the main imaging modalities available for the assessment of atherosclerotic burden and for potential prediction of future events. …
Ultrasound, computed tomography, magnetic resonance imaging (MRI), positron emission tomography (PET) and interventional angiography …
Bioresorbable scaffolds on the bench.
Ormiston J, Motreff P, Darremont O, Webber B, Guerin P, Webster M. Ormiston J, et al. EuroIntervention. 2015;11 Suppl V:V166-9. doi: 10.4244/EIJV11SVA40. EuroIntervention. 2015. PMID: 25983158 Free article. Review.
The safe pressure threshold for SB dilatation of a 3.0 mm Absorb scaffold with a 3.0 mm non-compliant balloon is 10 atm and for mini-KBPD with two 3.0 mm balloons it is 5 atm. Strategies such as culotte, crush and simultaneous kissing scaffolds (SKS) may not be appr …
The safe pressure threshold for SB dilatation of a 3.0 mm Absorb scaffold with a 3.0 mm non-compliant balloon is 10 atm and for mini-KBPD wi …
PET/CT and PET/MRI in ophthalmic oncology (Review).
Kalemaki MS, Karantanas AH, Exarchos D, Detorakis ET, Zoras O, Marias K, Millo C, Bagci U, Pallikaris I, Stratis A, Karatzanis I, Perisinakis K, Koutentakis P, Kontadakis GA, Spandidos DA, Tsatsakis A, Papadakis GZ. Kalemaki MS, et al. Int J Oncol. 2020 Feb;56(2):417-429. doi: 10.3892/ijo.2020.4955. Epub 2020 Jan 3. Int J Oncol. 2020. PMID: 31939615 Free PMC article. Review.
Addressing these challenges requires the employment of several diagnostic imaging techniques, such as high-definition digital fundus photography, ultrasound imaging, optical coherence tomography, optical coherence tomography (OCT)-angiography, computed tomography (C …
Addressing these challenges requires the employment of several diagnostic imaging techniques, such as high-definition digital fundus …
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study.
Kafka M, Giannini G, Artamonova N, Neuwirt H, Ofner H, Kramer G, Bauernhofer T, Luger F, Höfner T, Loidl W, Griessner H, Lusuardi L, Bergmaier A, Berger A, Winder T, Weiss S, Bauinger S, Krause S, Drerup M, Heinrich E, Schneider M, Madersbacher S, Vallet S, Stoiber F, Laimer S, Hruby S, Schachtner G, Nagele U, Lenart S, Ponholzer A, Pfuner J, Wiesinger C, Kamhuber C, Müldür E, Bektic J, Horninger W, Heidegger I. Kafka M, et al. Clin Genitourin Cancer. 2024 Apr;22(2):458-466.e1. doi: 10.1016/j.clgc.2023.12.018. Epub 2024 Jan 4. Clin Genitourin Cancer. 2024. PMID: 38267304 Free article.
Adverse events (AE) occurred in 61.9% with grade 3 to 5 in 15% of patient without age-related differences. All patients achieved a PSA decline of 99% and imaging response was confirmed in 88% of abiraterone and 75% of darolutamide patients. ...Regardless of selected therap …
Adverse events (AE) occurred in 61.9% with grade 3 to 5 in 15% of patient without age-related differences. All patients achieved a PSA decli …
Multiprotein Dynamic Combinatorial Chemistry: A Strategy for the Simultaneous Discovery of Subfamily-Selective Inhibitors for Nucleic Acid Demethylases FTO and ALKBH3.
Das M, Yang T, Dong J, Prasetya F, Xie Y, Wong KHQ, Cheong A, Woon ECY. Das M, et al. Chem Asian J. 2018 Oct 4;13(19):2854-2867. doi: 10.1002/asia.201800729. Epub 2018 Sep 14. Chem Asian J. 2018. PMID: 29917331
To expand the scope of DCC, herein, a novel multiprotein DCC strategy has been developed that combines the discriminatory power of a zwitterionic "thermal tag" with the sensitivity of differential scanning fluorimetry. ...Through this strategy, it was possibl …
To expand the scope of DCC, herein, a novel multiprotein DCC strategy has been developed that combines the discriminatory power of a …
1,013 results